• MRVL is trading 2.2% up at $283.79 after UBS reiterated its Buy rating and significantly increased its price target from $230 to $340, citing Marvell's strong position in the Compute Express Link (CXL) market.
  • UBS highlighted the CXL market's expected growth to $4.5 billion in 2027 and $7 billion to $10 billion by 2030, projecting Marvell to generate $1 billion in CXL revenue in 2027 and $2 billion in 2028.
  • The stock is extending a strong rebound, also supported by broader market sentiment and Nasdaq gains.